InvestorsHub Logo
Followers 33
Posts 2842
Boards Moderated 2
Alias Born 10/24/2015

Re: JohnLocke101 post# 49

Thursday, 07/01/2021 12:11:06 PM

Thursday, July 01, 2021 12:11:06 PM

Post# of 303
Clinical data testing an auto anti-BCMA CAR-T with another GSI was encouraging. The bORR was 100% (five VGPR and one PR), five were MRD negative, and at the data cutoff, no patient has relapsed, with a median follow-up of five months (range 1-11).

So this combo should improve the depth and duration of response.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DTIL News